XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 877 $ 401
Short-term investments 7 8
Accounts receivable, net 1,173 1,279
Inventories 1,234 1,450
Prepaid expenses and assets held for sale 60 261
Total current assets 3,351 3,399
Property, plant and equipment, net of accumulated depreciation of $3,532 and $3,428 2,332 2,370
Intangible assets, net of accumulated amortization of $322 and $299 1,295 1,303
Other non-current assets 547 570
Total assets 7,525 7,642
Current liabilities:    
Short-term borrowings 99 448
Accounts payable 604 778
Accrued liabilities and liabilities held for sale 552 546
Total current liabilities 1,255 1,772
Long-term debt 1,741 1,740
Other non-current liabilities 499 480
Total liabilities 3,495 3,992
Share-based payments subject to redemption 54 55
Redeemable non-controlling interests 7 43
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 shares issued at September 30, 2024 and December 31, 2023 1 1
Additional paid-in capital 1,145 1,146
Less: Treasury stock (common stock: 12.7 and 12.6 shares at September 30, 2024 and December 31, 2023) at cost (1,245) (1,207)
Accumulated other comprehensive loss (1,000) (1,056)
Retained earnings 5,049 4,654
Total Ingredion stockholders’ equity 3,950 3,538
Non-redeemable non-controlling interests 19 14
Total stockholders’ equity 3,969 3,552
Total liabilities and stockholders’ equity $ 7,525 $ 7,642